Skip to main content
. 2020 Aug 1;40(12):3469–3479. doi: 10.1007/s10792-020-01533-y

Table 2.

The results before and 4, 8, 12 weeks after treatment with LipiFlow® in the HMGD group

Project N Baseline 4 weeks 8 weeks 12 weeks
x¯±s x¯±s t P4 x¯±s t P8 x¯±s t P12
SPEED 25 12.12 ± 2.45 8.92 ± 2.14 13.443 < 0.001* 6.64 ± 1.68 16.784 < 0.001* 5.20 ± 1.96 18.086 < 0.001*
OSDI 25 24.12 ± 4.84 17.31 ± 4.71 2.394 < 0.001* 13.86 ± 4.21 14.276 < 0.001* 12.92 ± 4.12 15.95 < 0.001*
SIT/mm 25 1.48 ± 1.00 3.88 ± 1.17 − 7.719 < 0.001* 2.88 ± 1.27 − 4.427 < 0.001* 2.00 ± 1.35 − 1.641 0.114
NIKBUT/s 25 3.17 ± 1.40 5.49 ± 1.57 − 7.653 < 0.001* 3.77 ± 1.27 − 2.902 0.008* 2.95 ± 1.14 1.208 0.239
TMH/mm 25 0.19 ± 0.09 0.24 ± 0.09 − 19.092 < 0.001* 0.22 ± 0.09 − 10.533 < 0.001* 0.20 ± 0.09 − 4.301 < 0.001*
LLT/nm 25 44.40 ± 9.45 46.44 ± 9.79 − 8.981 < 0.001* 45.32 ± 9.75 − 2.326 0.029* 44.72 ± 9.16 − 0.969 0.342
PBR 25 0.61 ± 0.19 0.51 ± 0.17 13.843 < 0.001* 0.42 ± 0.15 16.794 < 0.001* 0.42 ± 0.14 13.913 < 0.001*

x¯±s: mean ± standard deviation; P4: P value at 4 weeks from baseline; P8: P value at 8 weeks from baseline; P12: P value at 12 weeks from baseline

SPEED Standard Patient Evaluation of Eye Dryness, OSDI Ocular Surface Disease Index, SIT Schirmer I test, NIKBUT noninvasive keratographic breakup time, TMH tear meniscus height, LLT lipid layer thickness, PBR partial blink rate

*Statistically significant